发明名称 Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
摘要 1,144,905. Chromone derivatives. FISONS PHARMACEUTICALS Ltd. 3 March, 1966 [25 March, 1965; 9 Dec., 1965; 17 Dec., 1965], Nos. 12626/65, 52414/65 and 53744/65. Heading C2C. [Also in Division A5] The invention comprises bis-chromonyl compounds of the formula and functional derivatives of carboxylic acid groups present in which R<SP>1</SP>, R<SP>2</SP>, R<SP>3</SP>, R<SP>4</SP>, R<SP>5</SP> and R<SP>6</SP> are the same or are different and each is a hydrogen or halogen atom or a hydroxy, alkyl, alkoxy, or substituted alkyl or alkoxy group and X is a saturated or unsaturated, substituted or unsubstituted, straight or branched hydrocarbon chain which may be interrupted by a carbocyclic or heterocyclic ring or one or more oxygen atoms or carbonyl groups, which are prepared by reacting in one or more stages a compound and a compound A-X<SP>1</SP>-B, in which Z is a hydroxy group and Y a hydrogen atom, a group -COCH 3 , or -COOR<SP>1</SP> (in which R<SP>1</SP> is an alkyl group), or Y and Z together form a chain (W is a carboxylic group or derivative or a group convertible thereto); Y<SP>1</SP> and Z<SP>1</SP> have the same meaning as Y and Z and may be the same as or different from Y and Z; A and B are the same or are different and each is a group capable of reacting with a hydroxyl group to form an ether linkage, or one of A and B is a group capable of being converted to such a reactive group; and X<SP>1</SP> is such that the group (in which A<SP>1</SP> and B<SP>1</SP> are the residues of A and B after the formation of ether linkages has the same meaning as X and thereafter converting Z and Y and Z<SP>1</SP> and Y<SP>1</SP> to chains or functional derivatives thereof to form the bis-(chromone-2-carboxylic acid). A preferred compound is 1,3-bis-(2-carboxychromon-5-yloxy)-2-hydroxypropane and many other compounds are claimed. Salts of the compounds with suitable cations, such as alkali and alkaline earth metals and organic bases are also described. Several embodiments of the preparation are described, for example the reaction of o-hydroxy-acetophenone with an oxalic acid derivative of formula in which R<SP>9</SP> is a halogen atom or a group -OR<SP>1</SP> (R<SP>1</SP> is alkyl) R<SP>10</SP> and R<SP>11</SP> are both halogens and R<SP>12</SP> is a group OR<SP>1</SP> or R<SP>10</SP> and R<SP>11</SP> together represent a carbonyl oxygen atom and R<SP>12</SP> is a halogen or -OR<SP>1</SP>. The compounds are used in pharmaceutical compositions in the treatment of asthma (see Division A5).
申请公布号 GB1144905(A) 申请公布日期 1969.03.12
申请号 GB19650012626 申请日期 1965.03.25
申请人 FISONS PHARMACEUTICALS LIMITED 发明人 FITZMAURICE COLIN;LEE THOMAS BRIAN;ALTOUNYAN ROGER EDWARD COLLINGWOOD
分类号 C07C45/00;C07C45/67;C07C45/71;C07C49/84;C07C67/00;C07D311/16;C07D311/22;C07D311/24 主分类号 C07C45/00
代理机构 代理人
主权项
地址